Adaptive Biotechnologies Corporation · NASDAQ:ADPT
BlackRock, Inc. reported a 7.90% stake in Adaptive Biotechnologies Corporation (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock, Inc. reported a 7.90% stake in Adaptive Biotechnologies Corporation, 11,992,448 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G/A).
- Stake
- 7.90%
- Shares
- 11,992,448
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 7.90% | 11,992,448 |
Source
Related
- Adaptive Biotechnologies Corporation
- BlackRock, Inc.
- Adaptive Biotechnologies Corporation shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 17, 2025
- Form 4 · Rubinstein Julie · Oct 16, 2026
- Form 4 · Rubinstein Julie · Oct 13, 2026
- Form 4 · Rubinstein Julie · Oct 8, 2026
- Form 4 · Bobulsky Susan · Oct 8, 2026
- Form 4 · Rubinstein Julie · Oct 5, 2026